Amantadine hydrochloride in the treatment of parkinsonism: a placebo-controlled double-blind study. 1971

B E Freedman, and E Getz, and J M MacGregor, and F R Ames

UI MeSH Term Description Entries
D007568 Jaw Bony structure of the mouth that holds the teeth. It consists of the MANDIBLE and the MAXILLA. Jaws
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D005684 Gait Manner or style of walking. Gaits
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

B E Freedman, and E Getz, and J M MacGregor, and F R Ames
June 2001, Journal of the American Academy of Child and Adolescent Psychiatry,
B E Freedman, and E Getz, and J M MacGregor, and F R Ames
July 2007, American journal of physical medicine & rehabilitation,
B E Freedman, and E Getz, and J M MacGregor, and F R Ames
August 1995, Clinical neuropharmacology,
B E Freedman, and E Getz, and J M MacGregor, and F R Ames
January 1974, Pharmacology,
B E Freedman, and E Getz, and J M MacGregor, and F R Ames
September 1996, Journal of neurology, neurosurgery, and psychiatry,
B E Freedman, and E Getz, and J M MacGregor, and F R Ames
October 1970, The Medical journal of Australia,
B E Freedman, and E Getz, and J M MacGregor, and F R Ames
July 1965, British medical journal,
B E Freedman, and E Getz, and J M MacGregor, and F R Ames
January 1999, Regional anesthesia and pain medicine,
B E Freedman, and E Getz, and J M MacGregor, and F R Ames
May 1996, Drug and alcohol dependence,
B E Freedman, and E Getz, and J M MacGregor, and F R Ames
January 1973, Diseases of the nervous system,
Copied contents to your clipboard!